|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2003-12-11
|
|
pubmed:abstractText |
Survival after first-line therapy is poor for patients with glioblastoma. The role of second-line treatment for recurrent disease is controversial. The authors studied the outcome in a subset of patients with glioblastoma who were selected for an aggressive reintervention strategy at the time of progression. Their objectives were to improve patients' overall survival with sustained quality of life and to make comparisons with overall survival in unselected patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:AllgäuerMichaelM,
pubmed-author:BaumgartUlrikeU,
pubmed-author:BockAnneA,
pubmed-author:BrawanskiAlexanderA,
pubmed-author:DietrichJörgJ,
pubmed-author:FabelKlausK,
pubmed-author:GrauerOliverO,
pubmed-author:JauchTanyaT,
pubmed-author:Klinkhammer-SchalkeMonikaM,
pubmed-author:KochHorstH,
pubmed-author:PetitJ PJP,
pubmed-author:PfeiferKatharinaK,
pubmed-author:SchlaierJuergenJ,
pubmed-author:SchuiererGerhardG,
pubmed-author:SteinbrecherAndreasA,
pubmed-author:UlrichBogdahnB,
pubmed-author:UlrichWinfriedW,
pubmed-author:WismethCaeciliaC
|
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2678-86
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14669289-Adult,
pubmed-meshheading:14669289-Aged,
pubmed-meshheading:14669289-Aged, 80 and over,
pubmed-meshheading:14669289-Antineoplastic Agents,
pubmed-meshheading:14669289-Brain Neoplasms,
pubmed-meshheading:14669289-Cohort Studies,
pubmed-meshheading:14669289-Combined Modality Therapy,
pubmed-meshheading:14669289-Female,
pubmed-meshheading:14669289-Follow-Up Studies,
pubmed-meshheading:14669289-Glioblastoma,
pubmed-meshheading:14669289-Humans,
pubmed-meshheading:14669289-Karnofsky Performance Status,
pubmed-meshheading:14669289-Male,
pubmed-meshheading:14669289-Middle Aged,
pubmed-meshheading:14669289-Neoplasm Recurrence, Local,
pubmed-meshheading:14669289-Neoplasm Staging,
pubmed-meshheading:14669289-Quality of Life,
pubmed-meshheading:14669289-Radiotherapy Dosage,
pubmed-meshheading:14669289-Reoperation,
pubmed-meshheading:14669289-Retrospective Studies,
pubmed-meshheading:14669289-Salvage Therapy,
pubmed-meshheading:14669289-Survival Rate
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Salvage therapy in patients with glioblastoma: is there any benefit?
|
|
pubmed:affiliation |
Klinik und Poliklinik für Neurologie der Universität Regensburg im Bezirksklinikum, Regensburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
